Heart Failure

Disease State Hub

FDA Alerts

treatment

FDA Approves Heart Failure Treatment

02/25/2022

The US Food and Drug Administration has approved a treatment option for adults with heart failure.

02/25/2022

Heart failure

FDA Approves New Oral Treatment Option for HFrEF

05/06/2020

It is the first sodium-glucose co-transporter 2 inhibitor to be approved to treat adults with New York Heart Association’s functional class II-IV heart failure with reduced ejection fraction.

05/06/2020

Heart failure

FDA: Novel Heart Failure Treatment Approved

07/08/2015

The FDA has approved new options for the treatment of heart failure and cystic fibrosis, and issued a warning on unapproved prescription ear drops.

07/08/2015

Heart Failure Snapshot

Reviewed by Michael Bloch, MD

For more cardiology content, visit our Resource Center

Heart failure is a chronic condition occurring when the heart cannot pump enough blood and oxygen to support the function of other organs.

For more primary care content, visit our Resource Center

HF Specialists, Cardiologists, Nurse Practitioners, Physician Assistants, Hospitalists, Primary Care Physicians, Pharmacists

For more on the presentation of heart failure, visit the Clinical Insights page

Symptoms include shortness of breath during usual activities or while lying down, cough, water retention, weight gain, swelling in feet, legs, ankles, or stomach, rapid heartbeat, and fatigue.

For more imaging content, visit our Resource Center

Blood test, chest x-ray, electrocardiogram, stress test, cardiac CT scan, MRI, coronary angiogram, myocardial biopsy, right heart catheterization

For more obesity content, visit our Disease State Hub

Hypertensio n, d iabete s, o besity, valvular heart disease, c oronary artery disease, s moking tobacco , eating foods high in fat, cholesterol, and sodium, not getting enough physical activity, and excessive alcohol intake

The four classes of the New York Heart Association Classification

Class I: No HF symptoms
Class II: Exertion causes shortness of breath or fatigue
Class III: Difficulty completing everyday activities
Class IV: Shortness of breath occurs at rest

American College of Cardiology/American Heart Association Stages of Heart Failure

Stage A: Several risk factors, no HF signs/symptoms
Stage B: Heart disease, no HF signs/symptoms
Stage C: Heart disease & signs of HF
Stage D: Requires specialized treatment

For more content on statins, visit our Resource Center

The number of women at high cardiovascular risk who did not accept their physician's initial recommendation of statin therapy.

Ref: Brown et al.

For more patient education content, visit our Resource Center

The lifetime risk of heart failure remains high: 20% to 45% after the age of 45 across all ethnic and racial groups.

Ref: Tsao et al.

October 2024

Current Issue

October 2024

Volume 64

Issue 9

Sources: